Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Seizures”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Post-approval studies (Phase 4)Ended earlyNCT00215215
What this trial is testing

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Who this might be right for
Epilepsies, Partial
Cyberonics, Inc. 360
Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Not applicableEnded earlyNCT05934903
What this trial is testing

Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus

Who this might be right for
Status EpilepticusRefractory Status Epilepticus
Yale University 4
Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Large-scale testing (Phase 3)WithdrawnNCT02726867
What this trial is testing

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Who this might be right for
EpilepsyStatus Epilepticus
Mid-Atlantic Epilepsy and Sleep Center, LLC
Not applicableStudy completedNCT05147571
What this trial is testing

RNS System NAUTILUS Study

Who this might be right for
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
NeuroPace 100
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Not applicableStudy completedNCT05830864
What this trial is testing

Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Hopital of Melun 66
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Large-scale testing (Phase 3)Ended earlyNCT00524134
What this trial is testing

P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.

Who this might be right for
Epilepsy
Columbia University 6
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Large-scale testing (Phase 3)Study completedNCT00699972
What this trial is testing

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 390
Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Not applicableEnded earlyNCT03154307
What this trial is testing

Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Who this might be right for
EpilepsyStatus EpilepticusEpilepsia Partialis Continua+1 more
Baptist Health South Florida 2
Testing effectiveness (Phase 2)Study completedNCT00152503
What this trial is testing

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Who this might be right for
Epilepsy, Partial
UCB Pharma SA 59
Testing effectiveness (Phase 2)Study completedNCT00887861
What this trial is testing

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

Who this might be right for
SeizuresEpilepsy
Novartis 37
Large-scale testing (Phase 3)Study completedNCT00266591
What this trial is testing

The Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Testing effectiveness (Phase 2)Study completedNCT03198949
What this trial is testing

A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)

Who this might be right for
Epilepsy and Focal Cortical Dysplasia II
Yonsei University 23
Load More Results